Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25
Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology
Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl
Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on May 30
Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
Nutriband Inc. Announces $8.4M Private Placement
To find out more, or to enquire about our partnership options, please contact our team who can help find the right solution for your business.
